These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3544176)

  • 21. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
    Pagani A; Pranzo A; Sala N; Galante T
    Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early liver damage caused by alcohol].
    Garcá Vigil JL; Aguirre García J; Pérez Muñoz HA; López Bárcena JJ; Lifshitz Guinzberg A
    Rev Gastroenterol Mex; 1980; 45(4):167-74. PubMed ID: 7466143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portal lymphocytic infiltrate in alcoholic liver disease.
    Colombat M; Charlotte F; Ratziu V; Poynard T
    Hum Pathol; 2002 Dec; 33(12):1170-4. PubMed ID: 12514784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic stellate cells and liver retinoid content in alcoholic liver disease in humans.
    Hautekeete ML; Dodeman I; Azais-Braesco V; Van den Berg K; Seynaeve C; Geerts A
    Alcohol Clin Exp Res; 1998 Apr; 22(2):494-500. PubMed ID: 9581658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The alcoholic liver: steatosis, hepatitis, cirrhosis, cancer].
    Barbare JC
    Soins; 1985 Mar; (449):3-4. PubMed ID: 2988133
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term management of alcoholic liver disease.
    Wakim-Fleming J; Mullen KD
    Clin Liver Dis; 2005 Feb; 9(1):135-49. PubMed ID: 15763233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcoholic liver disease in Scotland and northeastern England: presenting features in 510 patients.
    Hislop WS; Bouchier IA; Allan JG; Brunt PW; Eastwood M; Finlayson ND; James O; Russell RI; Watkinson G
    Q J Med; 1983; 52(206):232-43. PubMed ID: 6604294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
    Niemelä O; Risteli L; Sotaniemi EA; Risteli J
    Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic viral infection in patients with alcoholic liver involvement].
    Nikitin IG; Storozhakov GI; Volynkina VM; Uskov IuI; Kisliakov VA; Shilo VIu
    Ter Arkh; 1998; 70(2):40-4. PubMed ID: 9551570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features.
    Mathurin P; Beuzin F; Louvet A; Carrié-Ganne N; Balian A; Trinchet JC; Dalsoglio D; Prevot S; Naveau S
    Aliment Pharmacol Ther; 2007 May; 25(9):1047-54. PubMed ID: 17439505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and/or lobular hepatitis.
    Rosman AS; Paronetto F; Galvin K; Williams RJ; Lieber CS
    Arch Intern Med; 1993 Apr; 153(8):965-9. PubMed ID: 7683191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of cholylglycine in alcoholic hepatopathies. Clinical usefulness].
    Pagani A; Pranzo A; Galante T
    Minerva Dietol Gastroenterol; 1985; 31(1):25-31. PubMed ID: 4000510
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease.
    Baldi E; Burra P; Plebani M; Salvagnini M
    Ital J Gastroenterol; 1993 Oct; 25(8):429-32. PubMed ID: 8286777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcoholic liver disease in alcoholic chronic pancreatitis: a prospective study.
    Gullo L; Casadei R; Campione O; Grigioni W; Marrano D
    Ital J Gastroenterol; 1995 Mar; 27(2):69-72. PubMed ID: 7579594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excess weight risk factor for alcoholic liver disease.
    Naveau S; Giraud V; Borotto E; Aubert A; Capron F; Chaput JC
    Hepatology; 1997 Jan; 25(1):108-11. PubMed ID: 8985274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-epidemiological study of the prevalence and anatomoclinical forms of ethanol-induced hepatopathies].
    Banciu T; Berinde L; Prodan P; Pătroi F; Tudose N; Dăian E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):363-70. PubMed ID: 6120553
    [No Abstract]   [Full Text] [Related]  

  • 39. Is determination of the hepatic iron index of diagnostic value in patients with thalassemia minor and chronic alcoholic liver disease?
    Yebra M; Lacoma F; Queipo de Llano MP; Moreno ME
    Hepatology; 1991 Jun; 13(6):1264-5. PubMed ID: 2050344
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical characteristics of alcoholic liver diseases].
    Oancea R; Bojin S; Firescu E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(5):435-46. PubMed ID: 2894062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.